Havn Life Sciences

Havn Life Sciences to study psilocybin’s effect on the human immune system

Specifically, the study will determine if a single dose of psilocybin extract can affect the body’s inflammatory response

Havn Life Sciences Ivan Casselman Casselman

Havn Life Sciences chief psychedelic officer marries love of plants with desire to help

Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.

Havn Life psychedelics company

Vancouver psychedelics company Havn Life obtains Health Canada exemption

Health Minister Patty Hajdu has given its wholly owned subsidiary the green light to possess pure psilocybin for research purposes.